From: Breast conserving therapy for central breast cancer in the United States
Factor | OR | 95%CI | P-value |
---|---|---|---|
Age | < 0.001 | ||
< 45 | 1 | Reference | |
45–59 | 2.026 | 1.706–2.405 | < 0.001 |
60–79 | 2.581 | 2.182–3.053 | < 0.001 |
Race | < 0.001 | ||
White | 1 | Reference | |
Black | 1.030 | 0.874–1.213 | 0.725 |
Others | 0.680 | 0.585–0.79 | < 0.001 |
Marital | 0.059 | ||
Married | 1 | Reference | |
Single | 1.146 | 1.001–1.313 | 0.049 |
Divorced | 0.952 | 0.850–1.067 | 0.4 |
Year of diagnosis | 1.076 | 1.048–1.106 | < 0.001 |
Grade | 0.014 | ||
Grade I | 1 | Reference | |
Grade II | 0.843 | 0.747–0.951 | 0.005 |
Grade III | 0.819 | 0.707–0.949 | 0.008 |
Grade IV | 0.477 | 0.182–1.251 | 0.132 |
T stage | < 0.001 | ||
T1 | 1 | Reference | |
T2 | 0.447 | 0.402–0.496 | < 0.001 |
T3 | 0.152 | 0.118–0.195 | < 0.001 |
T4 | 0.182 | 0.134–0.247 | < 0.001 |
N stage | < 0.001 | ||
N0 | 1 | Reference | |
N1 | 0.634 | 0.57–0.706 | < 0.001 |
N2 | 0.304 | 0.242–0.381 | < 0.001 |
N3 | 0.216 | 0.150–0.311 | < 0.001 |
ER status | 0.987 | ||
Negative | 1 | Reference | |
Positive | 1.002 | 0.829–1.209 | 0.987 |
PR status | 0.082 | ||
Negative | 1 | Reference | |
Positive | 1.141 | 0.984–1.323 | 0.082 |
HER-2 status | 0.004 | ||
Negative | 1 | Reference | |
Positive | 0.822 | 0.719–0.94 | 0.004 |